Majority of Europeans trust technology to improve healthcare, Johnson & Johnson survey finds
May 8, 2025Research and Development AI, Corporate, Devices, EU Data Act, HCPs, Johnson & Johnson, Pharmacy, digital technology, survey
A global survey by Johnson & Johnson MedTech has revealed that a majority of Europeans are willing to share their …
Bristol Myers Squibb appoints Cari Gallman as executive vice president, general counsel and chief policy officer
May 8, 2025Business Services, Legal, Research and Development Corporate, appointment, bristol myers squibb
Global biopharma company, Bristol Myers Squibb, has announced the appointment of Cari Gallman as executive vice president, general counsel and …
Digital Control Room, a major pharma provider, wins King’s Award for Enterprise
May 7, 2025Business Services, Medical Communications Digital Control Room, King's Award for Enterprise, Pharma services, Pharmacy, UK
Buckingham Palace has announced that Digital Control Room, a software platform that monitors companies’ online content, will receive a King’s …
ENA Respiratory appoints two strategic advisors to support leading project
May 7, 2025Research and Development Ena Respiratory, Infections and infestations, Respirology, strategic adivsors
ENA Respiratory, focused on minimising the impact of viral respiratory infections, has announced the appointment of Kenny Simmen (pictured left) …
Alchemab Therapeutics signs $415m licensing agreement for ALS programme with Eli Lilly
May 7, 2025Mergers and Acquisitions Alchemab Therapeutics, Corporate, Eli Lilly and Company, Immunology, M&A, als, immunology, neurodegenerative conditions
Alchemab Therapeutics, an immunotherapy-focused biopharma company, has entered a licensing agreement with Eli Lilly and Company (Lilly) for ATLX-1282, its …
Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant
May 6, 2025Mergers and Acquisitions (OTC & VMS), Clayton, Clayton Dubilier & Rice (CD&R), Corporate, M&A, Opella, Sanofi, agreement
Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofi’s …
Genmab to submit FDA application for lymphoma therapy
May 2, 2025Research and Development AbbVie, Biologics License Application, FDA, Genmab, Oncology, epcoritamab, lymphoma, therapeutics
Global biotechnology company Genmab plans to submit a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) …
Ambitious plans for leading cancer research centre announced
May 2, 2025Market & Product Development, Medical Communications, Research and Development Aviva Capital Partners (ACP), Institute of Cancer Research (ICR), London, London Cancer Hub, Oncology, Royal Marsden NHS Foundation Trust, Socius
Aviva Capital Partners (ACP), an infrastructure and real estate investor, and Socius, a mixed-use developer, have unveiled plans for a …
Clinigen announces executive appointments to drive growth and investor value
May 1, 2025Business Services, Pharmaceutical Consultancy Services Clinigen, Keith Bryne, Nihad Hasagic, Pharma services, Pharmacy, appointment
Clinigen, the global pharmaceutical services group, has announced key leadership changes to accelerate its growth and strengthen its position in …
Tozaro appoints Jason Slingsby as CEO to lead commercial strategy in cell and gene therapy sector
May 1, 2025Manufacturing Services, Manufacturing and Production, Research and Development CEO, CGT, Jason Slingsby, Michele Pedrocchi, Pharmacy, Tozaro, manufacturing
Tozaro, a technology provider specialising in cell and gene therapy (CGT) manufacturing, has appointed Jason Slingsby (pictured left) as its …
Deadly cancers are being financially left behind, new research claims
May 1, 2025Research and Development Jude, Oncology, UK, bladder cancer, cancer research, charitable funding
New research has revealed that some of the UK’s most deadly and prevalent cancers receive the least amount of charitable …
Neogap chosen for Innovate Nordics 2025 Acceleration Programme
May 1, 2025Research and Development Innovate Nordics, Neogap Therapeutics, Oncology, biotech, funding programme, immunotherapy
Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics’ 2025 acceleration programme, a prestigious initiative designed to …
Cervical cancer experts campaign to increase screening rates and save lives
April 30, 2025Research and Development NHS, NHS England, Oncology, campaign, cervical cancer, screening
A coalition of experts fighting to end cervical cancer, referred to as the UK Consensus Group of the Advancing Cervical …
Novo Nordisk Foundation expands ambitious Challenge Programme internationallyÂ
April 30, 2025Research and Development Challenge Programme, Denmark, Novo Nordisk, Pharmacy, international
The Novo Nordisk Foundation Challenge Programme, a leading open competition grant programme, invites researchers outside of Denmark to participate and …
Gifthealth appoints Chip Parkinson as CEO to lead next phase of growth
April 29, 2025Business Services, Pharmaceutical Consultancy Services CEO, Gifthealth, Pharmacy, pharmacy care
Gifthealth, a technology-driven pharmacy care company, has appointed Chip Parkinson as its new chief executive officer. The move marks a …
Ryan Smith appointed as global head of sales at Astoriom
April 29, 2025Logistics & Distribution, Research and Development Astoriom, Pharmacy, appointment, sample storage solutions
Global R&D sample stability and biorepository storage company, Astoriom, has announced the appointment of Ryan Smith as global head of …
EU approval granted for rare kidney disease treatment
April 29, 2025Market Access, Research and Development, Sales and Marketing CSL Vifor, EU, Nephrology, Travere Therapeutics, kidney disease, nephrology
The EU has granted marketing authorisation (MA) for Filspari – CSL Vifor and Travere Therapeutics’ therapy for primary IgA nephropathy …
Study finds new test could better predict risk of heart disease
April 28, 2025Research and Development Cardiology, Chalmers University of Technologyu, Harvard, cholesterol tests, cvd
A study by Harvard University, US, and Chalmers University of Technology, Sweden, has found that measuring a lipoprotein marker combination …
Sobi and Sanofi’s Foundation S renew partnership with World Federation of Hemophilia
April 28, 2025Pharmacy sales & educational programmes, Sales and Marketing Haematology, Sanofi, World Federation of Hemophilia, bleeding disorder, sobi
Sobi and Sanofi, through its organisation Foundation S, have extended their partnership with the World Federation of Hemophilia (WFH) Humanitarian …
McDavid Stilwell appointed as CFO of CPTx
April 28, 2025Research and Development CPTx, Immunology, Oncology, appointment, cfo, therapeutics
CPTx, a German biotech company focused on single-stranded DNA therapeutics, has announced the appointment of McDavid Stilwell as chief financial …
Latest content
FibroFind appoints Lee Borthwick as CEO
